Capital Analysts LLC’s Integra LifeSciences IART Stock Holding History

Capital Analysts LLC’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-192	Closed	-$8K	–	1107
2022 Q3	$8K	Hold	192	–	–	﹤0.01%	838
2022 Q2	$10K	Hold	192	–	–	﹤0.01%	794
2022 Q1	$12K	Hold	192	–	–	﹤0.01%	725
2021 Q4	$13K	Hold	192	–	–	﹤0.01%	776
2021 Q3	$13K	Hold	192	–	–	﹤0.01%	760
2021 Q2	$13K	Hold	192	–	–	﹤0.01%	712
2021 Q1	$13K	Hold	192	–	–	﹤0.01%	762
2020 Q4	$12K	Hold	192	–	–	﹤0.01%	555
2020 Q3	$9K	Hold	192	–	–	﹤0.01%	595
2020 Q2	$9K	Hold	192	–	–	﹤0.01%	552
2020 Q1	$9K	Hold	192	–	–	﹤0.01%	529
2019 Q4	$11K	Hold	192	–	–	﹤0.01%	538
2019 Q3	$11K	Hold	192	–	–	﹤0.01%	529
2019 Q2	$11K	Hold	192	–	–	﹤0.01%	518
2019 Q1	$10K	Buy	+192	New	+$9.78K	﹤0.01%	507

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital Analysts LLC's IART Position: Q4 2022 in Review

Capital Analysts LLC sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 192 shares — an estimated $8K sold.

Capital Analysts LLC first reported a position in IART in Q1 2019 and held it in 15 quarters. The position peaked at $13K in Q4 2021. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

Capital Analysts LLC reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
Capital Analysts LLC sold 192 Integra LifeSciences shares in Q4 2022, an estimated $8K.
Capital Analysts LLC first reported a position in Integra LifeSciences in Q1 2019 and held it in 15 quarters.
Capital Analysts LLC's Integra LifeSciences position peaked at $13K in Q4 2021.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on Capital Analysts LLC's 13F filing for Q4 2022, filed 8 Feb 2023.